ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hyperimmune Globulin Injection Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-37I13935
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Hyperimmune Globulin Injection Market Research Report 2023
BUY CHAPTERS

Global Hyperimmune Globulin Injection Market Research Report 2025

Code: QYRE-Auto-37I13935
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Behring
Grifols S A
Biotest
Kedrion S p A
CBPO
Kamada
CNBG
Hualan Bio
Shanghai Raas
Sichuan Yuanda Shuyang
ADMA Biologics
Emergent

Hyperimmune Globulin Injection Market Size

The global market for Hyperimmune Globulin Injection was valued at US$ 2207 million in the year 2024 and is projected to reach a revised size of US$ 3391 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Hyperimmune Globulin Injection Market

Hyperimmune Globulin Injection Market

Hyperimmune Globulin is a highly concentrated immunoglobulin containing high levels of specific antibodies used for passive immunotherapy. It is usually extracted from the plasma of recovered patients who have been infected with a specific pathogen, so these people have produced high levels of antibodies against the pathogen.
Hyperimmune globulin is similar to intravenous immunoglobulin (IVIG) except that it is prepared from the plasma of donors with high titers of antibody against a specific organism or antigen. Some agents against which hyperimmune globulins are available include hepatitis B, rabies, tetanus toxin, varicella-zoster, etc. Administration of hyperimmune globulin provides "passive" immunity to the patient against an agent. This is in contrast to vaccines that provide "active" immunity. However, vaccines take much longer to achieve that purpose while hyperimmune globulin provides instant "passive" short-lived immunity. Hyperimmune globulin may have serious side effects, thus usage is taken very seriously.
The human plasma-based hyperimmune preparation market is driven by the increasing demand for effective treatments against specific infectious diseases and other medical conditions. Hyperimmune preparations are derived from the plasma of individuals who have recovered from a particular infection or have been vaccinated against a specific pathogen. These preparations contain high levels of antibodies targeting the specific pathogen or antigen, making them valuable for passive immunization in individuals at risk or currently affected by the same disease. The growing prevalence of infectious diseases, such as COVID-19, and the need for rapid and targeted therapeutic solutions have fueled market growth. Moreover, advancements in plasma fractionation and purification technologies have improved the production and safety of hyperimmune preparations. However, the market also faces challenges, including the complexity of large-scale plasma collection and processing, ensuring consistent antibody levels in the preparations, and maintaining a robust supply chain to meet demand during disease outbreaks or pandemics. Additionally, regulatory considerations and the need for stringent safety and quality standards are crucial challenges for manufacturers. To succeed in this market, companies must focus on research and development to expand the applications of hyperimmune preparations, collaborate with healthcare authorities and organizations to establish guidelines and protocols, and work towards enhancing plasma collection infrastructure to ensure a steady supply of human plasma-based hyperimmune preparations for critical therapeutic interventions.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyperimmune Globulin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperimmune Globulin Injection.
The Hyperimmune Globulin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hyperimmune Globulin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperimmune Globulin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hyperimmune Globulin Injection Market Report

Report Metric Details
Report Name Hyperimmune Globulin Injection Market
Accounted market size in year US$ 2207 million
Forecasted market size in 2031 US$ 3391 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Government Institution
  • Private Sector
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL Behring, Grifols, Biotest, Kedrion, Emergent, Kamada, CNBG, Hualan Bio, Shanghai RAAS, CBPO, Sichuan Yuanda Shuyang, ADMA Biologics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hyperimmune Globulin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hyperimmune Globulin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hyperimmune Globulin Injection Market growing?

Ans: The Hyperimmune Globulin Injection Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Hyperimmune Globulin Injection Market size in 2031?

Ans: The Hyperimmune Globulin Injection Market size in 2031 will be US$ 3391 million.

Who are the main players in the Hyperimmune Globulin Injection Market report?

Ans: The main players in the Hyperimmune Globulin Injection Market are CSL Behring, Grifols, Biotest, Kedrion, Emergent, Kamada, CNBG, Hualan Bio, Shanghai RAAS, CBPO, Sichuan Yuanda Shuyang, ADMA Biologics

What are the Application segmentation covered in the Hyperimmune Globulin Injection Market report?

Ans: The Applications covered in the Hyperimmune Globulin Injection Market report are Government Institution, Private Sector, Others

What are the Type segmentation covered in the Hyperimmune Globulin Injection Market report?

Ans: The Types covered in the Hyperimmune Globulin Injection Market report are Hepatitis B Immuneglobulins, Rabies Immuneglobulins, Tetanus Toxin Immuneglobulins, Rho(D) Immune Globulin, Cytomegalovirus Immune Globulin, Varicella-Zoster Immune Globulin, Others

Recommended Reports

Immunoglobulin Products

Infectious Disease Therapies

Immunology Diagnostics

1 Hyperimmune Globulin Injection Market Overview
1.1 Product Definition
1.2 Hyperimmune Globulin Injection by Type
1.2.1 Global Hyperimmune Globulin Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Hepatitis B Immuneglobulins
1.2.3 Rabies Immuneglobulins
1.2.4 Tetanus Toxin Immuneglobulins
1.2.5 Rho(D) Immune Globulin
1.2.6 Cytomegalovirus Immune Globulin
1.2.7 Varicella-Zoster Immune Globulin
1.2.8 Others
1.3 Hyperimmune Globulin Injection by Application
1.3.1 Global Hyperimmune Globulin Injection Market Value by Application (2024 VS 2031)
1.3.2 Government Institution
1.3.3 Private Sector
1.3.4 Others
1.4 Global Hyperimmune Globulin Injection Market Size Estimates and Forecasts
1.4.1 Global Hyperimmune Globulin Injection Revenue 2020-2031
1.4.2 Global Hyperimmune Globulin Injection Sales 2020-2031
1.4.3 Global Hyperimmune Globulin Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hyperimmune Globulin Injection Market Competition by Manufacturers
2.1 Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hyperimmune Globulin Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hyperimmune Globulin Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hyperimmune Globulin Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hyperimmune Globulin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyperimmune Globulin Injection, Product Type & Application
2.7 Global Key Manufacturers of Hyperimmune Globulin Injection, Date of Enter into This Industry
2.8 Global Hyperimmune Globulin Injection Market Competitive Situation and Trends
2.8.1 Global Hyperimmune Globulin Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hyperimmune Globulin Injection Players Market Share by Revenue
2.8.3 Global Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hyperimmune Globulin Injection Market Scenario by Region
3.1 Global Hyperimmune Globulin Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hyperimmune Globulin Injection Sales by Region: 2020-2031
3.2.1 Global Hyperimmune Globulin Injection Sales by Region: 2020-2025
3.2.2 Global Hyperimmune Globulin Injection Sales by Region: 2026-2031
3.3 Global Hyperimmune Globulin Injection Revenue by Region: 2020-2031
3.3.1 Global Hyperimmune Globulin Injection Revenue by Region: 2020-2025
3.3.2 Global Hyperimmune Globulin Injection Revenue by Region: 2026-2031
3.4 North America Hyperimmune Globulin Injection Market Facts & Figures by Country
3.4.1 North America Hyperimmune Globulin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hyperimmune Globulin Injection Sales by Country (2020-2031)
3.4.3 North America Hyperimmune Globulin Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyperimmune Globulin Injection Market Facts & Figures by Country
3.5.1 Europe Hyperimmune Globulin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hyperimmune Globulin Injection Sales by Country (2020-2031)
3.5.3 Europe Hyperimmune Globulin Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyperimmune Globulin Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Hyperimmune Globulin Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hyperimmune Globulin Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Hyperimmune Globulin Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hyperimmune Globulin Injection Market Facts & Figures by Country
3.7.1 Latin America Hyperimmune Globulin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hyperimmune Globulin Injection Sales by Country (2020-2031)
3.7.3 Latin America Hyperimmune Globulin Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyperimmune Globulin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyperimmune Globulin Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hyperimmune Globulin Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hyperimmune Globulin Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hyperimmune Globulin Injection Sales by Type (2020-2031)
4.1.1 Global Hyperimmune Globulin Injection Sales by Type (2020-2025)
4.1.2 Global Hyperimmune Globulin Injection Sales by Type (2026-2031)
4.1.3 Global Hyperimmune Globulin Injection Sales Market Share by Type (2020-2031)
4.2 Global Hyperimmune Globulin Injection Revenue by Type (2020-2031)
4.2.1 Global Hyperimmune Globulin Injection Revenue by Type (2020-2025)
4.2.2 Global Hyperimmune Globulin Injection Revenue by Type (2026-2031)
4.2.3 Global Hyperimmune Globulin Injection Revenue Market Share by Type (2020-2031)
4.3 Global Hyperimmune Globulin Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hyperimmune Globulin Injection Sales by Application (2020-2031)
5.1.1 Global Hyperimmune Globulin Injection Sales by Application (2020-2025)
5.1.2 Global Hyperimmune Globulin Injection Sales by Application (2026-2031)
5.1.3 Global Hyperimmune Globulin Injection Sales Market Share by Application (2020-2031)
5.2 Global Hyperimmune Globulin Injection Revenue by Application (2020-2031)
5.2.1 Global Hyperimmune Globulin Injection Revenue by Application (2020-2025)
5.2.2 Global Hyperimmune Globulin Injection Revenue by Application (2026-2031)
5.2.3 Global Hyperimmune Globulin Injection Revenue Market Share by Application (2020-2031)
5.3 Global Hyperimmune Globulin Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Company Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Behring Hyperimmune Globulin Injection Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Grifols
6.2.1 Grifols Company Information
6.2.2 Grifols Description and Business Overview
6.2.3 Grifols Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Grifols Hyperimmune Globulin Injection Product Portfolio
6.2.5 Grifols Recent Developments/Updates
6.3 Biotest
6.3.1 Biotest Company Information
6.3.2 Biotest Description and Business Overview
6.3.3 Biotest Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Biotest Hyperimmune Globulin Injection Product Portfolio
6.3.5 Biotest Recent Developments/Updates
6.4 Kedrion
6.4.1 Kedrion Company Information
6.4.2 Kedrion Description and Business Overview
6.4.3 Kedrion Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kedrion Hyperimmune Globulin Injection Product Portfolio
6.4.5 Kedrion Recent Developments/Updates
6.5 Emergent
6.5.1 Emergent Company Information
6.5.2 Emergent Description and Business Overview
6.5.3 Emergent Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Emergent Hyperimmune Globulin Injection Product Portfolio
6.5.5 Emergent Recent Developments/Updates
6.6 Kamada
6.6.1 Kamada Company Information
6.6.2 Kamada Description and Business Overview
6.6.3 Kamada Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Kamada Hyperimmune Globulin Injection Product Portfolio
6.6.5 Kamada Recent Developments/Updates
6.7 CNBG
6.7.1 CNBG Company Information
6.7.2 CNBG Description and Business Overview
6.7.3 CNBG Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CNBG Hyperimmune Globulin Injection Product Portfolio
6.7.5 CNBG Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Company Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hualan Bio Hyperimmune Globulin Injection Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 Shanghai RAAS
6.9.1 Shanghai RAAS Company Information
6.9.2 Shanghai RAAS Description and Business Overview
6.9.3 Shanghai RAAS Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Shanghai RAAS Hyperimmune Globulin Injection Product Portfolio
6.9.5 Shanghai RAAS Recent Developments/Updates
6.10 CBPO
6.10.1 CBPO Company Information
6.10.2 CBPO Description and Business Overview
6.10.3 CBPO Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 CBPO Hyperimmune Globulin Injection Product Portfolio
6.10.5 CBPO Recent Developments/Updates
6.11 Sichuan Yuanda Shuyang
6.11.1 Sichuan Yuanda Shuyang Company Information
6.11.2 Sichuan Yuanda Shuyang Description and Business Overview
6.11.3 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product Portfolio
6.11.5 Sichuan Yuanda Shuyang Recent Developments/Updates
6.12 ADMA Biologics
6.12.1 ADMA Biologics Company Information
6.12.2 ADMA Biologics Description and Business Overview
6.12.3 ADMA Biologics Hyperimmune Globulin Injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 ADMA Biologics Hyperimmune Globulin Injection Product Portfolio
6.12.5 ADMA Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hyperimmune Globulin Injection Industry Chain Analysis
7.2 Hyperimmune Globulin Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyperimmune Globulin Injection Production Mode & Process Analysis
7.4 Hyperimmune Globulin Injection Sales and Marketing
7.4.1 Hyperimmune Globulin Injection Sales Channels
7.4.2 Hyperimmune Globulin Injection Distributors
7.5 Hyperimmune Globulin Injection Customer Analysis
8 Hyperimmune Globulin Injection Market Dynamics
8.1 Hyperimmune Globulin Injection Industry Trends
8.2 Hyperimmune Globulin Injection Market Drivers
8.3 Hyperimmune Globulin Injection Market Challenges
8.4 Hyperimmune Globulin Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Behring
Grifols S A
Biotest
Kedrion S p A
CBPO
Kamada
CNBG
Hualan Bio
Shanghai Raas
Sichuan Yuanda Shuyang
ADMA Biologics
Emergent
List of Tables
 Table 1. Global Hyperimmune Globulin Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hyperimmune Globulin Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hyperimmune Globulin Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hyperimmune Globulin Injection Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hyperimmune Globulin Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hyperimmune Globulin Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hyperimmune Globulin Injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hyperimmune Globulin Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hyperimmune Globulin Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hyperimmune Globulin Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Hyperimmune Globulin Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hyperimmune Globulin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperimmune Globulin Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hyperimmune Globulin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hyperimmune Globulin Injection Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hyperimmune Globulin Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Hyperimmune Globulin Injection Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hyperimmune Globulin Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Hyperimmune Globulin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hyperimmune Globulin Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Hyperimmune Globulin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hyperimmune Globulin Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Hyperimmune Globulin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hyperimmune Globulin Injection Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hyperimmune Globulin Injection Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hyperimmune Globulin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hyperimmune Globulin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hyperimmune Globulin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hyperimmune Globulin Injection Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hyperimmune Globulin Injection Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hyperimmune Globulin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hyperimmune Globulin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hyperimmune Globulin Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hyperimmune Globulin Injection Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hyperimmune Globulin Injection Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hyperimmune Globulin Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hyperimmune Globulin Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hyperimmune Globulin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hyperimmune Globulin Injection Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hyperimmune Globulin Injection Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hyperimmune Globulin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hyperimmune Globulin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hyperimmune Globulin Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hyperimmune Globulin Injection Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hyperimmune Globulin Injection Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hyperimmune Globulin Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hyperimmune Globulin Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hyperimmune Globulin Injection Sales (K Units) by Type (2020-2025)
 Table 51. Global Hyperimmune Globulin Injection Sales (K Units) by Type (2026-2031)
 Table 52. Global Hyperimmune Globulin Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Hyperimmune Globulin Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Hyperimmune Globulin Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hyperimmune Globulin Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Hyperimmune Globulin Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Hyperimmune Globulin Injection Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hyperimmune Globulin Injection Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hyperimmune Globulin Injection Sales (K Units) by Application (2020-2025)
 Table 61. Global Hyperimmune Globulin Injection Sales (K Units) by Application (2026-2031)
 Table 62. Global Hyperimmune Globulin Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Hyperimmune Globulin Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Hyperimmune Globulin Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hyperimmune Globulin Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Hyperimmune Globulin Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Hyperimmune Globulin Injection Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hyperimmune Globulin Injection Price (US$/Unit) by Application (2026-2031)
 Table 70. CSL Behring Company Information
 Table 71. CSL Behring Description and Business Overview
 Table 72. CSL Behring Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Behring Hyperimmune Globulin Injection Product
 Table 74. CSL Behring Recent Developments/Updates
 Table 75. Grifols Company Information
 Table 76. Grifols Description and Business Overview
 Table 77. Grifols Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Grifols Hyperimmune Globulin Injection Product
 Table 79. Grifols Recent Developments/Updates
 Table 80. Biotest Company Information
 Table 81. Biotest Description and Business Overview
 Table 82. Biotest Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Biotest Hyperimmune Globulin Injection Product
 Table 84. Biotest Recent Developments/Updates
 Table 85. Kedrion Company Information
 Table 86. Kedrion Description and Business Overview
 Table 87. Kedrion Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Kedrion Hyperimmune Globulin Injection Product
 Table 89. Kedrion Recent Developments/Updates
 Table 90. Emergent Company Information
 Table 91. Emergent Description and Business Overview
 Table 92. Emergent Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Emergent Hyperimmune Globulin Injection Product
 Table 94. Emergent Recent Developments/Updates
 Table 95. Kamada Company Information
 Table 96. Kamada Description and Business Overview
 Table 97. Kamada Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Kamada Hyperimmune Globulin Injection Product
 Table 99. Kamada Recent Developments/Updates
 Table 100. CNBG Company Information
 Table 101. CNBG Description and Business Overview
 Table 102. CNBG Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CNBG Hyperimmune Globulin Injection Product
 Table 104. CNBG Recent Developments/Updates
 Table 105. Hualan Bio Company Information
 Table 106. Hualan Bio Description and Business Overview
 Table 107. Hualan Bio Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hualan Bio Hyperimmune Globulin Injection Product
 Table 109. Hualan Bio Recent Developments/Updates
 Table 110. Shanghai RAAS Company Information
 Table 111. Shanghai RAAS Description and Business Overview
 Table 112. Shanghai RAAS Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Shanghai RAAS Hyperimmune Globulin Injection Product
 Table 114. Shanghai RAAS Recent Developments/Updates
 Table 115. CBPO Company Information
 Table 116. CBPO Description and Business Overview
 Table 117. CBPO Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. CBPO Hyperimmune Globulin Injection Product
 Table 119. CBPO Recent Developments/Updates
 Table 120. Sichuan Yuanda Shuyang Company Information
 Table 121. Sichuan Yuanda Shuyang Description and Business Overview
 Table 122. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sichuan Yuanda Shuyang Hyperimmune Globulin Injection Product
 Table 124. Sichuan Yuanda Shuyang Recent Developments/Updates
 Table 125. ADMA Biologics Company Information
 Table 126. ADMA Biologics Description and Business Overview
 Table 127. ADMA Biologics Hyperimmune Globulin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. ADMA Biologics Hyperimmune Globulin Injection Product
 Table 129. ADMA Biologics Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Hyperimmune Globulin Injection Distributors List
 Table 133. Hyperimmune Globulin Injection Customers List
 Table 134. Hyperimmune Globulin Injection Market Trends
 Table 135. Hyperimmune Globulin Injection Market Drivers
 Table 136. Hyperimmune Globulin Injection Market Challenges
 Table 137. Hyperimmune Globulin Injection Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hyperimmune Globulin Injection
 Figure 2. Global Hyperimmune Globulin Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hyperimmune Globulin Injection Market Share by Type: 2024 & 2031
 Figure 4. Hepatitis B Immuneglobulins Product Picture
 Figure 5. Rabies Immuneglobulins Product Picture
 Figure 6. Tetanus Toxin Immuneglobulins Product Picture
 Figure 7. Rho(D) Immune Globulin Product Picture
 Figure 8. Cytomegalovirus Immune Globulin Product Picture
 Figure 9. Varicella-Zoster Immune Globulin Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Hyperimmune Globulin Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Hyperimmune Globulin Injection Market Share by Application: 2024 & 2031
 Figure 13. Government Institution
 Figure 14. Private Sector
 Figure 15. Others
 Figure 16. Global Hyperimmune Globulin Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Hyperimmune Globulin Injection Market Size (2020-2031) & (US$ Million)
 Figure 18. Global Hyperimmune Globulin Injection Sales (2020-2031) & (K Units)
 Figure 19. Global Hyperimmune Globulin Injection Average Price (US$/Unit) & (2020-2031)
 Figure 20. Hyperimmune Globulin Injection Report Years Considered
 Figure 21. Hyperimmune Globulin Injection Sales Share by Manufacturers in 2024
 Figure 22. Global Hyperimmune Globulin Injection Revenue Share by Manufacturers in 2024
 Figure 23. Global 5 and 10 Largest Hyperimmune Globulin Injection Players: Market Share by Revenue in Hyperimmune Globulin Injection in 2024
 Figure 24. Hyperimmune Globulin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 25. Global Hyperimmune Globulin Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 26. North America Hyperimmune Globulin Injection Sales Market Share by Country (2020-2031)
 Figure 27. North America Hyperimmune Globulin Injection Revenue Market Share by Country (2020-2031)
 Figure 28. United States Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Canada Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Europe Hyperimmune Globulin Injection Sales Market Share by Country (2020-2031)
 Figure 31. Europe Hyperimmune Globulin Injection Revenue Market Share by Country (2020-2031)
 Figure 32. Germany Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. France Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. U.K. Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Italy Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Russia Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Asia Pacific Hyperimmune Globulin Injection Sales Market Share by Region (2020-2031)
 Figure 38. Asia Pacific Hyperimmune Globulin Injection Revenue Market Share by Region (2020-2031)
 Figure 39. China Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Japan Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. South Korea Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. India Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Australia Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. China Taiwan Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Southeast Asia Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Latin America Hyperimmune Globulin Injection Sales Market Share by Country (2020-2031)
 Figure 47. Latin America Hyperimmune Globulin Injection Revenue Market Share by Country (2020-2031)
 Figure 48. Mexico Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Brazil Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Argentina Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Middle East and Africa Hyperimmune Globulin Injection Sales Market Share by Country (2020-2031)
 Figure 52. Middle East and Africa Hyperimmune Globulin Injection Revenue Market Share by Country (2020-2031)
 Figure 53. Turkey Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Saudi Arabia Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. UAE Hyperimmune Globulin Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Global Sales Market Share of Hyperimmune Globulin Injection by Type (2020-2031)
 Figure 57. Global Revenue Market Share of Hyperimmune Globulin Injection by Type (2020-2031)
 Figure 58. Global Hyperimmune Globulin Injection Price (US$/Unit) by Type (2020-2031)
 Figure 59. Global Sales Market Share of Hyperimmune Globulin Injection by Application (2020-2031)
 Figure 60. Global Revenue Market Share of Hyperimmune Globulin Injection by Application (2020-2031)
 Figure 61. Global Hyperimmune Globulin Injection Price (US$/Unit) by Application (2020-2031)
 Figure 62. Hyperimmune Globulin Injection Value Chain
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Hyperimmune Globulin Product Market Research Report 2024
Global Human Hyperimmune Globulins Market Research Report 2024
Global Hyperimmune Globulins Market Research Report 2025
Hyper Immune Globulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Plasma derived Hyperimmune Product Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Plasma based Hyperimmune Preparation Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intravenous Immunoglobulin IVIg Market Research Report 2025
Global Intravenous Immune Globulin Therapies Market Research Report 2024
IVIg Liquid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Intravenous Antibodies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVIg Powder Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Lyophilized IVIG Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Human Rabies Immune Globulin HRIG Market Research Report 2024
Global Human Immunoglobulin pH4 for Intravenous Injection Market Research Report 2024
Global Human Immunoglobulin pH4 for Intravenous Injection COVID 19 Market Research Report 2024
Global Prophylactic Gamma Globulin Market Research Report 2024
Human Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Immune Globulin Intravenous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Normal Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Human Varicella Zoster Immunoglobulin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions